MCI OneHealth Continues to Accelerate Precision Medicine and Technology Roadmap Through the Acquisition of Khure Health

MCI (TSX: DRDR) has signed a share purchase agreement to acquire all of the issued and outstanding shares of Khure (the “Transaction”). Khure’s technology platform harnesses clinical data, enabling physicians to rapidly screen and identify patients with rare diseases and facilitate more personalized treatment. Khure will be integrated into MCI’s primary care footprint, one of the first of its kind in Canada. About MCI MCI is a healthcare technology company focused on empowering patients and doctors with advanced technologies to increase access, improve quality, and reduce healthcare costs. As part of the healthcare community for over 30 years, MCI operates one of Canada’s leading primary care networks with 25 clinics, serves over 850,000 patients annually and had over 260,000 telehealth visits last year. MCI additionally offers an expanding suite of occupational health service offerings that support a growing list of over 250 corporate customers. led by a proven management team of doctors and experienced executives, MCI remains focused on executing a strategy centered around acquiring technology and health services that complement MCI’s current roadmap. For more information, visit mcionehealth.com.
（以上内容由医药魔方AI生成）